期刊文献+

药械组合产品质量管理体系建立及监管的探讨 被引量:3

Discussion on the Establishment and Supervision of Quality Management System for the Combination Products
下载PDF
导出
摘要 药械组合产品具有特殊性,如何建立质量管理体系,如何对质量管理体系进行有效监管是个值得探讨的问题。该文对国内外体系监管现状分析药械组合产品质量管理体系建设及监管中存在的问题,给出相关意见建议,以期为相关企业的体系建立及监管部门提供参考。 Combination products have special characteristics,how to establish quality management system and how to effectively supervise the quality management system is a problem worth discussing.The paper analyzes the existing problems in the quality management system construction and supervision of combination products from the current situation of system supervision at home and abroad,and gives relevant suggestions,in order to provide reference for the system establishment and supervision departments.
作者 刘凤林 柴谦 郭金双 张云娟 杨阳 董丹丹 陈洪忠 LIU Feng-lin;CHAI Qian;GUO Jin-shuang;ZHANG Yun-juan;YANG Yang;DONG Dan-dan;CHEN Hong-zhong(Shandong Center for Food and Drug Evaluation and Inspection,Shandong Jinan 250000;State Key Laboratory of Structural Chemistry,Fujian Institute of Research on the Structure of Matter,Chinese Academy of Sciences,Fujian Fuzhou 350002)
出处 《中国医疗器械信息》 2022年第13期10-12,共3页 China Medical Device Information
关键词 药械组合产品 质量管理体系 监管 combination product quality management system supervision
  • 相关文献

参考文献5

二级参考文献28

  • 1宓现强,王聪,潘尔顿,于勇,陈洁.国内外医疗器械上市后监督管理的比较及启示[J].中国医院管理,2008,28(12). 被引量:7
  • 2许伟,蓝翁驰.药械组合产品的监管对策探讨[J].中国医疗器械信息,2009,15(8):50-52. 被引量:8
  • 3[7]European Commission.PART 2 Guidelines for the Classification of Medical Devices(EU MEDDEV 2.4/1)(Z),Jul 1,2001.
  • 4[1]US FDA.Medical Device User Fee and Modernization Act (MDUFMA) of 2002[z].http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/Overview/MedicalDeviceUserFeeandModernizationActMDUFMA/ucm109135.pdf,PUBLIC LAW 107-250-OCT.26,2002.
  • 5[2]US FDA.Definition of Primary Mode of Action of a Combination Product[Z].http://edocket.access.gpo.gov/2005/pdf/05-16527.pdf,August 25,2005.
  • 6[3]US FDA.Manual of Standard Operating Procedures and Policies/Intercenter Consultative/Collaborative Riview Process[Z].June 18,2004.
  • 7[5]European Commission.Council Directive 93/42/EECconcerning medical devices.[Z]http://www.mdss.com/MDEV/93 42 EEC.htm,June 14,1993
  • 8[6]European Commission.Draft Commission Proposal,COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices[Z].http://europa.eu.int/comm/enterprise/medical devices/consult.htm,April 5,2005.
  • 9国家食品药品监督管理局,关于药械组合产品注册有关事宜的通告[EB/OL].http://www.sfda.gov.cn/WS01/CL0087/43215.html.
  • 10US FDA. CFR-Code of Federal Regulations Tide 21 [ EB/OL]. [2014-04- 01]. http://www, accessdata, fda. gov / scripts / cdrh / cfdocs / cfcfr / CFRSearch. cfmfr = 3. 2.

共引文献16

同被引文献12

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部